Drug Trial Radar · NCT00781859
Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.
Last checked: Nov 20, 2026Latest source record: Dec 17, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
326
Actual
Start
Dec 2008
Primary completion
Mar 2010
Study completion Apr 2010
Sponsor
- Lead sponsor
- ThromboGenicsIndustry
- Sponsor type
- Industry
- First posted
- Oct 29, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this trial is to evaluate the safety and efficacy of intravitreal microplasmin 125µg dose in subjects wiht focal vitreomacular adhesion.
Conditions
- Vitreomacular Adhesion
Interventions
125 µg OcriplasminDrug
125µg ocriplasmin intravitreal injection
PlaceboDrug
Placebo intravitreal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects With Nonsurgical Resolution of Focal Vitreomacular Adhesion at Day 28.Time frame: Day 28
Locations
41 sites in 1 country. Site status is shown where the registry gives one.
Retinal Consultants of AZ
Phoenix, Arizona
Assocaited Retina Consultants, Ltd.
Phoenix, Arizona
Retina Centers, P.C.
Tucson, Arizona
Retina Vitreous Associate Medical Group
Beverly Hills, California
VMR Institute
Huntington Beach, California
Jules Stein Eye Institute/UCLA
Los Angeles, California
Southern California Desert Retina Consultants
Palm Springs, California
Retinal Consultants Medical Group
Sacramento, California
Rocky Mountain Lions Eye Institute
Aurora, Colorado
Colorado Retina Associates, PC
Denver, Colorado
National Ophthalmologic Research Institute
Fort Meyers, Florida
University of Miami-Bascom Palmer Eye Institute- Palm Beach
Palm Beach, Florida
Sarasota Retina Institute
Sarasota, Florida
Center for Retina and Macular Disease
Winter Haven, Florida
Southeast Retina Center, PC
Augusta, Georgia
Rush University Med. Ctr
Chicago, Illinois
Midwest Eye Institute
Indianapolis, Indiana
Univ. Of Kentuck/Kentucky-Clinic/Dept of Ophthal & VS
Lexington, Kentucky
Maine Vitreoretinal Consultants, LLC, PA
Bangor, Maine
National Retina Institute
Towson, Maryland
University of Michigan-Kellogg Eye Center
Ann Arbor, Michigan
Kresge Eye Institute
Detroit, Michigan
Vitreo-Retinal Associates
Grand Rapids, Michigan
Associated Retina Consultants
Royal Oak, Michigan
Vitroretinal Surgery PA
Minneapolis, Minnesota
Retina Vitreous Centre, PA
New Brunswick, New Jersey
Retina Association of NJ
Teaneck, New Jersey
New York Eye and Ear Infirmary
New York, New York
Columbia University - Harkness Eye Institute
New York, New York
Retina Vitreous Surgeons of Central NY
New York, New York
Duke Eye Center
Durham, North Carolina
Caroline Eye Associates
Southern Pines, North Carolina
Wake Forest University Eye Center
Winston-Salem, North Carolina
Retina Association of Cleveland
Lakewood, Ohio
Pennsylvania Retina Specialists, P.C.
Camp Hill, Pennsylvania
Allegheny Ophthalmic & Orbital Associates, PC
Pittsburgh, Pennsylvania
Souteastern Retina Associates
Kingsport, Tennessee
Austin Retina Associates
Austin, Texas
Vitroretinal Consultants
Houston, Texas
Valley Retina Institute, P.A.
McAllen, Texas
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.